Các bài viết có thể truy cập công khai - Michael HaydenTìm hiểu thêm
Tổng thểCIHRNIHGenome CanadaMSFHRA*StarNSERCFCTMRCFWFDFGHuntington Society of CansdaHSFSwedish Research CouncilWellcomeEuropean CommissionGovernment of SpainNMRCHHMIFRQSNCNNSFSNSFNOAANHMRCCCSNSFCHelmholtzSFIDBTTelethonNWOBank of Sweden Tercentenary FoundationAlzheimers's UKBBSRCNIHRParkinson's UKANRMultiple Sclerosis Society of CanadaBMBFGovernment of ItalyMichael J Fox Foundation
Không có ở bất kỳ nơi nào: 44
Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline‐induced cardiotoxicity in children
H Visscher, CJD Ross, SR Rassekh, GSS Sandor, HN Caron, ...
Pediatric blood & cancer 60 (8), 1375-1381, 2013
Các cơ quan ủy nhiệm: Canadian Institutes of Health Research, Genome Canada
HDL and LDL cholesterol significantly influence β-cell function in type 2 diabetes mellitus
JK Kruit, LR Brunham, CB Verchere, MR Hayden
Current opinion in lipidology 21 (3), 178-185, 2010
Các cơ quan ủy nhiệm: Canadian Institutes of Health Research
Cholesterol metabolism in Huntington disease
JM Karasinska, MR Hayden
Nature Reviews Neurology 7 (10), 561-572, 2011
Các cơ quan ủy nhiệm: Canadian Institutes of Health Research
Therapeutic approaches to Huntington disease: from the bench to the clinic
NS Caron, ER Dorsey, MR Hayden
Nature Reviews Drug Discovery 17 (10), 729-750, 2018
Các cơ quan ủy nhiệm: Canadian Institutes of Health Research
Putting proteins in their place: palmitoylation in Huntington disease and other neuropsychiatric diseases
FB Young, SL Butland, SS Sanders, LM Sutton, MR Hayden
Progress in neurobiology 97 (2), 220-238, 2012
Các cơ quan ủy nhiệm: Canadian Institutes of Health Research
Caspase-6 and neurodegeneration
RK Graham, DE Ehrnhoefer, MR Hayden
Trends in neurosciences 34 (12), 646-656, 2011
Các cơ quan ủy nhiệm: Austrian Science Fund, Canadian Institutes of Health Research
Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington disease
S Franciosi, JK Ryu, Y Shim, A Hill, C Connolly, MR Hayden, ...
Neurobiology of disease 45 (1), 438-449, 2012
Các cơ quan ủy nhiệm: Canadian Institutes of Health Research
Phosphorylation of huntingtin reduces the accumulation of its nuclear fragments
SC Warby, CN Doty, RK Graham, J Shively, MR Hayden
Molecular and Cellular Neuroscience 40 (2), 121-127, 2009
Các cơ quan ủy nhiệm: Canadian Institutes of Health Research
Genetic Variants in SLC22A17 and SLC22A7 are Associated With Anthracycline-Induced Cardiotoxicity in Children
H Visscher, SR Rassekh, GS Sandor, HN Caron, EC Van Dalen, ...
Pharmacogenomics 16 (10), 1065-1076, 2015
Các cơ quan ủy nhiệm: Canadian Institutes of Health Research, Genome Canada
Loss of Cyp8b1 improves glucose homeostasis by increasing GLP-1
A Kaur, JV Patankar, W de Haan, P Ruddle, N Wijesekara, AK Groen, ...
Diabetes 64 (4), 1168-1179, 2015
Các cơ quan ủy nhiệm: Canadian Institutes of Health Research
The role of free fatty acids, pancreatic lipase and Ca2+ signalling in injury of isolated acinar cells and pancreatitis model in lipoprotein lipase‐deficient mice
F Yang, Y Wang, L Sternfeld, JA Rodriguez, C Ross, MR Hayden, ...
Acta physiologica 195 (1), 13-28, 2009
Các cơ quan ủy nhiệm: German Research Foundation
Palmitoylation and function of glial glutamate transporter-1 is reduced in the YAC128 mouse model of Huntington disease
K Huang, MH Kang, C Askew, R Kang, SS Sanders, J Wan, NG Davis, ...
Neurobiology of disease 40 (1), 207-215, 2010
Các cơ quan ủy nhiệm: US National Institutes of Health, Canadian Institutes of Health Research
Enhanced susceptibility to pancreatitis in severe hypertriglyceridaemic lipoprotein lipase-deficient mice and agonist-like function of pancreatic lipase in pancreatic cells
Y Wang, L Sternfeld, F Yang, JA Rodriguez, C Ross, MR Hayden, ...
Gut 58 (3), 422-430, 2009
Các cơ quan ủy nhiệm: German Research Foundation
Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study
R Reilmann, A McGarry, ID Grachev, JM Savola, B Borowsky, E Eyal, ...
The Lancet Neurology 18 (2), 165-176, 2019
Các cơ quan ủy nhiệm: US National Institutes of Health, German Research Foundation, UK Medical …
Adverse drug reaction active surveillance: developing a national network in Canada's children's hospitals
BC Carleton, RL Poole, MA Smith, JS Leeder, R Ghannadan, CJD Ross, ...
Pharmacoepidemiology and drug safety 18 (8), 713-721, 2009
Các cơ quan ủy nhiệm: Genome Canada
CAG size-specific risk estimates for intermediate allele repeat instability in Huntington disease
A Semaka, C Kay, C Doty, JA Collins, EK Bijlsma, F Richards, ...
Journal of Medical Genetics 50 (10), 696-703, 2013
Các cơ quan ủy nhiệm: Canadian Institutes of Health Research
ABCA1 influences neuroinflammation and neuronal death
JM Karasinska, W de Haan, S Franciosi, P Ruddle, J Fan, JK Kruit, ...
Neurobiology of disease 54, 445-455, 2013
Các cơ quan ủy nhiệm: Canadian Institutes of Health Research
Personalized gene silencing therapeutics for Huntington disease
C Kay, NH Skotte, AL Southwell, MR Hayden
Clinical genetics 86 (1), 29-36, 2014
Các cơ quan ủy nhiệm: US National Institutes of Health, Canadian Institutes of Health Research
Prediction of codeine toxicity in infants and their mothers using a novel combination of maternal genetic markers
J Sistonen, P Madadi, CJ Ross, M Yazdanpanah, JW Lee, ...
Clinical Pharmacology & Therapeutics 91 (4), 692-699, 2012
Các cơ quan ủy nhiệm: Canadian Institutes of Health Research, Genome Canada
Unstable familial transmissions of Huntington disease alleles with 27–35 CAG repeats (intermediate alleles)
A Semaka, JA Collins, MR Hayden
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 153 …, 2010
Các cơ quan ủy nhiệm: Canadian Institutes of Health Research
Chương trình máy tính sẽ tự động xác định thông tin xuất bản và thông tin về nhà tài trợ